Convalescent plasma use reduces hospitalisation in unvaccinated COVID-19 patients

Convalescent plasma use in people unvaccinated against COVID-19 significantly reduced the need for hospitalisation due to disease progression, according to a US study. Convalescent plasma (CP) use in people unvaccinated against COVID-19 within 9 days of symptom onset, led to a significant reduction in the proportion of individuals requiring hospital admission due to disease progression. This was the conclusion of a randomised, double-blind, controlled trial by a multidisciplinary group of researchers from New York, US.